Nothing Special   »   [go: up one dir, main page]

NL7700244A - PROCESS FOR THE PREPARATION OF PHTHALAND DERIVATIVES. - Google Patents

PROCESS FOR THE PREPARATION OF PHTHALAND DERIVATIVES.

Info

Publication number
NL7700244A
NL7700244A NL7700244A NL7700244A NL7700244A NL 7700244 A NL7700244 A NL 7700244A NL 7700244 A NL7700244 A NL 7700244A NL 7700244 A NL7700244 A NL 7700244A NL 7700244 A NL7700244 A NL 7700244A
Authority
NL
Netherlands
Prior art keywords
phthaland
derivatives
preparation
phthaland derivatives
Prior art date
Application number
NL7700244A
Other languages
Dutch (nl)
Other versions
NL192451B (en
NL192451C (en
Original Assignee
Kefalas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9722860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7700244(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kefalas As filed Critical Kefalas As
Publication of NL7700244A publication Critical patent/NL7700244A/en
Publication of NL192451B publication Critical patent/NL192451B/en
Application granted granted Critical
Publication of NL192451C publication Critical patent/NL192451C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7700244A 1976-01-14 1977-01-12 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative. NL192451C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1486/76A GB1526331A (en) 1976-01-14 1976-01-14 Phthalanes
GB148676 1976-01-14

Publications (3)

Publication Number Publication Date
NL7700244A true NL7700244A (en) 1977-07-18
NL192451B NL192451B (en) 1997-04-01
NL192451C NL192451C (en) 1997-08-04

Family

ID=9722860

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7700244A NL192451C (en) 1976-01-14 1977-01-12 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.
NL970031C NL970031I1 (en) 1976-01-14 1997-08-04 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL970031C NL970031I1 (en) 1976-01-14 1997-08-04 Process for the preparation of phthalan derivatives and process for the preparation of pharmaceutical preparations containing a phthalan derivative.

Country Status (19)

Country Link
US (1) US4136193A (en)
JP (1) JPS52105162A (en)
AT (1) AT359488B (en)
AU (1) AU509445B2 (en)
BE (1) BE850401A (en)
CA (1) CA1094087A (en)
CH (3) CH626886A5 (en)
DE (1) DE2657013C2 (en)
DK (1) DK143275C (en)
ES (1) ES454980A1 (en)
FI (1) FI63754C (en)
FR (1) FR2338271A1 (en)
GB (1) GB1526331A (en)
IE (1) IE44055B1 (en)
NL (2) NL192451C (en)
NO (2) NO147243C (en)
NZ (1) NZ183001A (en)
SE (1) SE429551B (en)
ZA (1) ZA7757B (en)

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602035A (en) * 1983-12-07 1986-07-22 Hoechst-Roussel Pharmaceuticals Inc. Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EP0759299B1 (en) * 1995-08-16 2000-04-26 Eli Lilly And Company Potentiation of serotonin response
DE69801764T2 (en) 1997-07-08 2002-07-04 H. Lundbeck A/S, Kobenhavn-Valby METHOD FOR PRODUCING CITALOPRAM
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
HUP0002953A3 (en) * 1997-11-11 2002-12-28 Lundbeck & Co As H Method for preparation of citalopram and intermediates used for them
EA002977B1 (en) 1998-10-20 2002-12-26 Х.Лундбекк А/С Method for the preparation of citalopram
AR021509A1 (en) * 1998-12-08 2002-07-24 Lundbeck & Co As H BENZOFURAN DERIVATIVES, ITS PREPARATION AND USE
KR20010081071A (en) 1998-12-08 2001-08-25 피터슨 존 메이달 Benzofuran derivatives, their preparation and use
JP2002533450A (en) 1998-12-23 2002-10-08 ハー・ルンドベック・アクチエゼルスカベット Method for producing 5-cyanophthalide
AR022329A1 (en) 1999-01-29 2002-09-04 Lundbeck & Co As H METHOD FOR THE PREPARATION OF 5-CYANOFTALIDE
CN1142926C (en) * 1999-04-14 2004-03-24 H·隆德贝克有限公司 Method for preparing citalopram
ITMI991581A1 (en) * 1999-06-25 2001-01-15 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM
ITMI991579A1 (en) * 1999-06-25 2001-01-15 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM
ITMI991486A1 (en) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A PROCESS FOR THE SYNTHESIS OF CITALOPRAM
AR021155A1 (en) * 1999-07-08 2002-06-12 Lundbeck & Co As H TREATMENT OF NEUROTIC DISORDERS
CH692298A5 (en) * 1999-10-25 2002-04-30 Lundbeck & Co As H Preparation of citalopram as antidepressant drug and for treating dementia and cerebrovascular disorders comprises reaction of a new intermediate with 3-(N,N-dimethylamino)propyl magnesium halide
DE69920526T2 (en) 1999-10-25 2006-02-23 H. Lundbeck A/S PROCESS FOR THE PREPARATION OF CITALOPRAM
AR026063A1 (en) 1999-11-01 2002-12-26 Lundbeck & Co As H METHOD FOR THE PREPARATION OF 5-CARBOXIFTALIDA.
US6310222B1 (en) * 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
IL150335A0 (en) * 1999-12-28 2002-12-01 Lundbeck & Co As H Method for the preparation of citalopram
JP2003519218A (en) * 1999-12-30 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット Method for producing citalopram
TR200201783T2 (en) * 2000-01-14 2002-12-23 H. Lundbeck A/S 5-Method for preparing cyanophatalide
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
NL1017415C1 (en) * 2000-02-24 2001-05-18 Lundbeck & Co As H Process for the preparation of Citalopram.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017417C1 (en) * 2000-03-03 2001-03-16 Lundbeck & Co As H Process for the preparation of Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
NL1017500C1 (en) 2000-03-13 2001-04-26 Lundbeck & Co As H Process for the preparation of Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
EP1265883A1 (en) 2000-03-13 2002-12-18 H. Lundbeck A/S Method for the preparation of citalopram
EP1265881A1 (en) * 2000-03-13 2002-12-18 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
CN1418205A (en) 2000-03-14 2003-05-14 H·隆德贝克有限公司 method for preparation of citalopram
CH692148A5 (en) * 2000-03-16 2002-02-28 Lundbeck & Co As H Process for making citalopram.
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
KR100821912B1 (en) * 2000-05-12 2008-04-16 하. 룬트벡 아크티에 셀스카브 Method for the preparation of citalopram
AR032455A1 (en) * 2000-05-12 2003-11-12 Lundbeck & Co As H METHOD FOR THE PREPARATION OF CITALOPRAM, AN INTERMEDIARY EMPLOYED IN THE METHOD, A METHOD FOR THE PREPARATION OF THE INTERMEDIARY EMPLOYED IN THE METHOD AND PHARMACEUTICAL COMPOSITION ANTIDEPRESSIVE
CA2383963A1 (en) * 2000-07-06 2002-01-17 Eva Bolzonella Method for the preparation of citalopram
UA75081C2 (en) * 2000-07-21 2006-03-15 Lundbeck & Co As H Inhibitors of the glycine transporter, use thereof and a pharmaceutical composition based thereon
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
IT1319686B1 (en) * 2000-12-12 2003-10-23 C D Farmasint S R L CITALOPRAM PREPARATION PROCEDURE.
SK284428B6 (en) * 2000-12-22 2005-04-01 H. Lundbeck A/S Process for preparation of citalopram
CA2359810C (en) * 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
DE10112828C1 (en) * 2000-12-28 2002-11-21 Lundbeck & Co As H Preparation of high purity citalopram comprises a cyanide exchange reaction followed by thin film distillation and recrystallization from methanol and water
DE10164725B4 (en) * 2000-12-28 2004-08-26 H. Lundbeck A/S Process for the preparation of purified citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
EP1355897A1 (en) 2001-01-30 2003-10-29 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
US20040133017A1 (en) * 2001-02-22 2004-07-08 Pulla Reddy Muddasani Process for the preparation of citalopram
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
CA2439856A1 (en) * 2001-03-09 2002-09-19 Swargam Sathyanarayana Process for the preparation of citalopram
KR20040030609A (en) * 2001-05-01 2004-04-09 하. 룬트벡 아크티에 셀스카브 The use of enantiomeric pure escitalopram
BG65271B1 (en) * 2001-06-18 2007-11-30 H. Lundbeck A/S Method for the preparation of citalopram
AR034759A1 (en) * 2001-07-13 2004-03-17 Lundbeck & Co As H METHOD FOR THE PREPARATION OF ESCITALOPRAM
IN192057B (en) * 2001-07-19 2004-02-14 Ranbaxy Lab Ltd
PL366995A1 (en) * 2001-07-31 2005-02-07 H.Lundbeck A/S Crystalline composition containing escitalopram
EP1288211A1 (en) * 2001-08-28 2003-03-05 Sekhsaria Chemicals Ltd. Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
AU2002342045C1 (en) * 2001-10-12 2009-07-30 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin Vla antagonists
IN192863B (en) * 2001-11-13 2004-05-22 Ranbaxy Lab Ltd
IS7239A (en) * 2001-12-14 2004-04-29 H. Lundbeck A/S Process for the production of acitalopram
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
TWI332938B (en) * 2002-03-27 2010-11-11 Bando Chemical Ind Novel 1,3,5-tris(arylamino)benzenes
CA2381341A1 (en) * 2002-04-09 2003-10-09 Torcan Chemical Ltd. Process and intermediates for preparing escitalopram
FI20021421A0 (en) * 2002-07-30 2002-07-30 Orion Corp Fermion Production Process
PE20040991A1 (en) 2002-08-12 2004-12-27 Lundbeck & Co As H SEPARATION OF INTERMEDIARIES FOR THE PREPARATION OF ESCITALOPRAM
WO2004016602A1 (en) * 2002-08-14 2004-02-26 Natco Pharma Limited Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
GB2385051B (en) * 2002-08-29 2003-12-24 Max India Ltd Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
PT1578738E (en) * 2002-12-23 2008-04-11 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
AU2003242990A1 (en) * 2003-01-17 2004-08-13 Pulla Reddy Muddasani Processes for the preparation of escitalopram and its precursor
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc Method and composition for treating neurodegenerative disorders
ITMI20030479A1 (en) * 2003-03-13 2004-09-14 Adorkem Technology S P A PROCEDURE FOR THE PREPARATION OF A CYAN-ISOBENZOFURANO.
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
CA2532207A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
ITFI20030202A1 (en) * 2003-07-28 2005-01-29 Synteco Spa PROCESS FOR THE PREPARATION OF DERIVATIVES DEL
EA200801812A1 (en) * 2003-09-17 2009-06-30 Янссен Фармацевтика Н.В. CONJUGATED HETEROCYCLIC COMPOUNDS
PT1506963E (en) * 2003-10-28 2005-08-31 Adorkem Technology Spa PROCESS FOR THE PREPARATION OF CITALOPRAM
WO2005042473A1 (en) * 2003-10-28 2005-05-12 Wockhardt Limited Improved process for the manufacture of citalopram hydrobromide
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
CA2547639A1 (en) * 2003-12-02 2005-06-16 B&B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
EP2343073A3 (en) 2003-12-11 2011-10-12 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CN100569765C (en) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 Citalopram intermediate crystalline base
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20080119662A1 (en) * 2004-02-16 2008-05-22 Jubilant Organosys Limted One Spot Synthesis of Citalopram from 5-Cyanophthalide
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (en) * 2004-04-09 2004-07-09 Adorkem Technology Spa CHEMO-ENZYMATIC PROCEDURE FOR THE PREPARATION OF ESCITALOPRAM
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Lithium combinations, and uses related thereto
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
WO2006021971A2 (en) 2004-08-23 2006-03-02 Sun Pharmaceutical Industries Limited 'process for preparation of citalopram and enantiomers'
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
PE20070093A1 (en) * 2005-04-22 2007-02-07 Wyeth Corp DIHYDROBENZOPHURAN DERIVATIVES AS MODULATORS OF THE 5-HT2C RECEIVER
EP1871358A1 (en) 2005-04-22 2008-01-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
MX2007012883A (en) 2005-04-22 2007-12-10 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof.
CA2603900A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
WO2007008758A2 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
US8048874B2 (en) 2005-07-19 2011-11-01 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
JP2009502807A (en) * 2005-07-22 2009-01-29 ミリアド ジェネティクス， インコーポレイテッド Formulations and dosage forms with high drug content
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20090247772A1 (en) * 2005-11-14 2009-10-01 H. Lundbeck A/S Method for the Preparation of Escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
FR2912057B1 (en) * 2007-02-07 2009-04-17 Sanofi Aventis Sa PHARMACEUTICAL COMPOSITION COMPRISING SAREDUTANT AND A SELECTIVE SEROTONIN RECAPTURE INHIBITOR OR SEROTONIN / NOREPINEPHRINE RECAPTURE INHIBITOR
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007112014A2 (en) * 2006-03-24 2007-10-04 Wyeth New therapeutic combinations for the treatment of depression
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007249435A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
KR20090064418A (en) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 Combinations containing a 4-acylaminopyridine derivative
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP4927497B2 (en) * 2006-10-25 2012-05-09 株式会社シスコ Moisture-free hopper equipment
CN100457747C (en) * 2006-11-21 2009-02-04 浙江大学 Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
WO2008086483A2 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
PT1988086E (en) 2007-04-23 2012-02-28 Synthon Bv Process for resolving citalopram via its (s)-enriched citalopram tartrate compound.
EP2155710A2 (en) * 2007-05-18 2010-02-24 Cipla Limited Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the s-isomer
US20080312318A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched escitalopram
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
US8022232B2 (en) * 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
KR101103118B1 (en) * 2007-11-02 2012-01-04 동아제약주식회사 Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition for the treatment of premature ejaculation thereof
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
EP2116231A1 (en) 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
US20100087664A1 (en) * 2008-10-07 2010-04-08 Ravindra Vedantham Preparation of citalopram and salts thereof
GR20080100696A (en) 2008-10-23 2010-05-13 Genepharm �.�. Taste masked dosage form of pharmaceutically aceptable salt of escitalopram
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
USRE48841E1 (en) 2009-10-23 2021-12-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
EP3351104B1 (en) 2010-07-01 2020-12-09 Azevan Pharmaceuticals, Inc. Compounds for use in the treatment of intermittent explosive disorder
WO2013100870A1 (en) 2011-12-02 2013-07-04 Mahmut Bilgic New antipsychotic compositions
WO2013081567A1 (en) 2011-12-02 2013-06-06 Mahmut Bilgic Effervescent antipsychotic formulations
WO2013110313A1 (en) * 2012-01-23 2013-08-01 H. Lundbeck A/S Selective allosteric modulators of the serotonin transporter
NZ724718A (en) 2014-03-28 2023-04-28 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
SI3426251T1 (en) 2016-03-10 2022-07-29 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
CA3075759A1 (en) 2017-09-15 2019-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (en) * 1965-03-18

Also Published As

Publication number Publication date
IE44055B1 (en) 1981-07-29
NO1996001I1 (en) 1996-01-05
NO770109L (en) 1977-07-15
NL970031I2 (en) 1997-10-01
NO147243C (en) 1983-03-02
CH626886A5 (en) 1981-12-15
AU509445B2 (en) 1980-05-15
ZA7757B (en) 1977-11-30
NZ183001A (en) 1978-06-02
CH632259A5 (en) 1982-09-30
BE850401A (en) 1977-07-14
FR2338271B1 (en) 1982-11-05
FI63754B (en) 1983-04-29
DE2657013C2 (en) 1985-11-14
DK143275C (en) 1982-01-18
DE2657013A1 (en) 1977-07-28
JPS52105162A (en) 1977-09-03
ATA947276A (en) 1980-04-15
IE44055L (en) 1977-07-14
FI770073A (en) 1977-07-15
AT359488B (en) 1980-11-10
SE429551B (en) 1983-09-12
SE7614201L (en) 1977-07-15
DK13177A (en) 1977-07-15
GB1526331A (en) 1978-09-27
CA1094087A (en) 1981-01-20
ES454980A1 (en) 1978-04-01
CH632258A5 (en) 1982-09-30
AU2107377A (en) 1978-07-13
US4136193A (en) 1979-01-23
NL192451B (en) 1997-04-01
NL970031I1 (en) 1997-10-01
NL192451C (en) 1997-08-04
NO147243B (en) 1982-11-22
FI63754C (en) 1983-08-10
JPS6135986B2 (en) 1986-08-15
DK143275B (en) 1981-08-03
FR2338271A1 (en) 1977-08-12

Similar Documents

Publication Publication Date Title
NL7700244A (en) PROCESS FOR THE PREPARATION OF PHTHALAND DERIVATIVES.
NL7708180A (en) PROCESS FOR THE PREPARATION OF TETRAELKYL-BIS -CYCLOHEXYLAMINE DERIVATIVES.
NL183033C (en) PROCESS FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLYCIN.
NL178684C (en) PROCESS FOR THE PREPARATION OF DIALKYLOXALATES
NL7703892A (en) PROCESS FOR THE PREPARATION OF MALEINEIMIDES.
NL7702420A (en) PROCESS FOR THE PREPARATION OF FORMAMIDS.
NL7709748A (en) PROCESS FOR THE PREPARATION OF METHOXYPSORALES.
NL189129C (en) PROCESS FOR THE PREPARATION OF ACYLCYANIDES
NL189088C (en) PROCESS FOR THE PREPARATION OF ACYLCYANIDES
NL7707729A (en) PROCESS FOR THE PREPARATION OF 5-M-TOLYLOXYURACIL.
NL7707229A (en) PROCESS FOR THE PREPARATION OF METHYLDICHLOROPHOSPHANE.
NL7708091A (en) Process for the preparation of phenoxy-phenoxy-alkanecarboxylic acid derivatives.
NL188996C (en) PROCESS FOR THE PREPARATION OF ACYLCYANIDES
NL7707763A (en) PROCESS FOR THE PREPARATION OF METHYLDICHLOROPHOSPHANE.
NL7706508A (en) PROCESS FOR THE PREPARATION OF P-ISOBUTYLHYDRATROPATE QUAJACOL.
NL7710336A (en) PROCESS FOR THE PREPARATION OF ANTHRACHINONE DERIVATIVES.
NL7610048A (en) PROCESS FOR THE PREPARATION OF DIPHENYLAMINE DERIVATIVES.
NL7711156A (en) PROCESS FOR THE PREPARATION OF N-ALKYLANILINS.
NL7710442A (en) PROCESS FOR THE CONTINUOUS PREPARATION OF ACETOACEETAMIDES.
NL7709237A (en) PROCESS FOR THE PREPARATION OF 3-METHYL-2-P- HALOGENOPHENYLBUTYRONITRILE.
NL7713440A (en) PROCESS FOR THE PREPARATION OF AMIDINS.
NL7705897A (en) PROCESS FOR THE PREPARATION OF POLYSACCHARIDE-1.
NL7702238A (en) PROCESS FOR THE PREPARATION OF PYRIDYLPHOS FOR ACID DERIVATIVES.
NL189511C (en) PROCESS FOR THE PREPARATION OF THIOCARBONOHYDRAZIDE.
NL7701401A (en) PROCESS FOR THE PREPARATION OF OLEANDOMYCINE DERIVATIVES.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: LUNDBECK & CO., A/S. H. -

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: LUNDBECK A/S. H. -

AC1 Application for a supplementary protection certificate

Free format text: 970031, 970804

KC1 Grant of a supplementary protection certificate

Free format text: 970031, 19970112, EXPIRES: 20020111

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 970804